1. |
Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic RouxenY gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women [J]. Obes Surg, 2009, 19(5): 577582.
|
2. |
Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition [J]. Lancet, 2005, 366(9491): 10591062.
|
3. |
Sjstrm L, Narbro K, Sjstrm CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects [J]. N Engl J Med, 2007, 357(8): 741752.
|
4. |
Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13 871 morbidly obese patients from a national registry [J]. Ann Surg, 2007, 246(6): 10021009.
|
5. |
Yarbrough DE, Leath RR, Leeth TD, et al. Longterm improvement of gastrointestinal complaints following weight loss in patients undergoing laparoscopic RouxenY gastric bypass (LRYGBP) [J]. ASMBS, 2006, 2(3): 296297.
|
6. |
Bose M, Oliván B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? [J]. Obes Surg, 2009, 19(2): 217229.
|
7. |
Puzziferri N, AustrheimSmith IT, Wolfe BM, et al. Threeyear followup of a prospective randomized trial comparing laparoscopic versus open gastric bypass [J]. Ann Surg, 2006, 243(2): 181188.
|
8. |
Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10y followup [J]. Am J Clin Nutr, 1992, 55(2 Suppl): 582S585S.
|
9. |
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial [J]. JAMA, 2008, 299(3): 316323.
|
10. |
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis [J]. Am J Med, 2009, 122(3): 248256.
|
11. |
Rossi M, R Barretto Ferreira da Silva R, Chaves Alcntara G Jr, et al. Remission of metabolic syndrome: a study of 140 patients six months after RouxenY gastric bypass [J]. Obes Surg, 2008, 18(5): 601606.
|
12. |
Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following RouxenY gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity [J]. Obes Surg, 2007, 17(2): 176184.
|
13. |
Zlabek JA, Grimm MS, Larson CJ, et al. The effect of laparosscopic gastric bypss surgery on dyslipidemia in severely obese patients [J]. Surg Obes Relat Dis, 2005, 1(6): 537542.
|
14. |
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and metaanalysis [J]. JAMA, 2004, 292(14): 17241737.
|
15. |
Ali MR, Fuller WD, Rasmussen J. Detailed description of early response of metabolic syndrome after laparoscopic RouxenY gastric bypass [J]. Surg Obes Relat Dis, 2009, 5(3): 346351.
|
16. |
邓治洲, 王烈, 林忆阳, 等. 胃转流术对非肥胖型2型糖尿病的疗效观察及其对胰高血糖样肽1的影响 [J]. 中国普外基础与临床杂志, 2009, 244(9): 466469.
|
17. |
Scopinaro N, Papadia F, Marinari G, et al. Longterm control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2 [J]. Obes Surg, 2007, 17(2): 185192.
|
18. |
Couzin J. Bypassing medicine to treat diabetes [J]. Science, 2008, 320(5875): 438440.
|
19. |
DePaula AL, MacedoAL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 2034 [J]. Surg Endosc, 2008, 23(8): 17241732.
|
20. |
Ballantyne GH, Farkas D, Laker S, et al. Shortterm changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic RouxenY gastric bypass [J]. Obes Surg, 2006, 16(9): 11891197.
|
21. |
Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding [J]. J Clin Endocrinol Metab, 2006, 91(4): 15781581.
|
22. |
Koh KK, Quon MJ, Lee SJ, et al. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension [J]. Diabetes Care, 2007, 30(6): 16051607.
|
23. |
Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men [J]. JAMA, 2004, 291(14): 17301737.
|
24. |
Choi KM, Lee J, Lee KW, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans [J]. Clin Endocrinol (Oxf), 2004, 61(1): 7580.
|
25. |
Choi EY, Park EH, Cheong YS, et al. Association of Creactive protein with the metabolic risk factors among young and middleaged Korean [J]. Metabolism, 2006, 55(3): 415421.
|
26. |
GómezAmbrosi J, Pastor C, Salvador J, et al. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass [J]. Obes Surg, 2007, 17(5): 585591.
|
27. |
Kotronen A, SepplLindroos A, Bergholm R, et al. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome [J]. Diabetologia, 2008, 5(1): 130138.
|
28. |
Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of RouxenY gastric bypass surgery on rat intestinal glucose transport [J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297(5): G950G957.
|
29. |
Rao MN, Mulligan K, Tai V, et al. Effects of insulinlike growth factor (IGF)I/IGFbinding protein3 treatment on glucose metabolism and fat distribution in human immunodeficiency virusinfected patients with abdominal obesity and insulin resistance [J]. J Clin Endocrinol Metab, 2010, 95(9): 43614366.
|
30. |
Wang X, Zhang S, Chen Y, et al. APM1 gene variants11377C/G and 4545G/C are associated respectively with obesity and with nonobesity in Chinese type 2 diabetes [J]. Diabetes Res Clin Pract, 2009, 84(3): 205210.
|
31. |
Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations [J]. Diab Vasc Dis Res, 2007, 4(1): 1319.
|
32. |
Swarbrick MM, Stanhope KL, AustrheimSmith IT, et al. Longitudinal changes in pancreatic and adipocyte hormone following RouxenY gastric bypass surgery [J]. Diabetolog, 2008, 51(10): 19011911.
|
33. |
周龙翔, 汪昱, 杨喆, 等. 胃癌术后不同残胃患者胃肠激素及机体组成变化 [J]. 中国普外基础与临床杂志, 2009, 16(4): 290295.
|